SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?

To: teevee who wrote (594)10/19/2001 3:03:11 PM
From: scaram(o)uche  Respond to of 656
 
Maintenance of transplants? Fine. The molecule looks like it has a good shot to me, backed by solid science. I haven't taken a close look, so I won't judge it otherwise. Autoimmunity? No chance, IMO.



To: teevee who wrote (594)10/19/2001 3:25:58 PM
From: scaram(o)uche  Read Replies (3) | Respond to of 656
 
On further comment........ I've looked at Isotechnika, on occasion, for many years. I'm interested in the company.

Universal immunosuppression kills people. That's my bias.

I'm interested in the company for the transplantation work, and have been for some time. It's a very risky business plan, however.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News